Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,845,055
+$2,889,294 QoQ
Shares Held
343,898
+10.9% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. DNLI ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,845,055 | 343,898 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,955,761 | 310,196 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,819,861 | 291,936 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,622,259 | 249,467 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,074,930 | 219,795 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,575,257 | 189,427 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,475,719 | 121,478 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,011,352 | 206,363 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,698,906 | 116,232 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,347,527 | 114,402 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,698,321 | 79,139 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,822,721 | 88,353 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,742,097 | 92,921 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,910,866 | 82,937 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,467,831 | 88,739 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,390,597 | 77,895 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,167,989 | 73,666 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,175,784 | 67,634 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,983,093 | 44,464 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,432,597 | 48,218 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,086,837 | 383,565 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $1,521,885 | 26,653 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,805,281 | 212,575 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,264,914 | 314,399 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,002,889 | 289,615 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,081,489 | 290,205 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||